Switching from a first to a second tumour necrosis factor (TNF) alpha antagonist in patients with juvenile idiopathic arthritis

被引：0
|
作者：
H Schmeling
G Horneff
机构：
[1] Hospital for Sick Children,
[2] Asklepios Klinik,undefined
来源：
Pediatric Rheumatology | / 6卷 / Suppl 1期
关键词：
Public Health; Adverse Event; Arthritis; Tumour Necrosis; Tumour Necrosis Factor;
D O I：
10.1186/1546-0096-6-S1-P41
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Drug survival of the first and second course of anti-tumour necrosis factor agents in juvenile idiopathic arthritis
    Tynjala, P.
    Vahasalo, P.
    Honkanen, V.
    Lahdenne, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (04) : 552 - 557
  • [2] Tumour necrosis factor alpha promoter polymorphisms and etanercept therapy in juvenile idiopathic arthritis
    Schmeling, Heinrike
    Horneff, Gerd
    RHEUMATOLOGY INTERNATIONAL, 2007, 27 (04) : 383 - 386
  • [3] Tumour necrosis factor alpha promoter polymorphisms and etanercept therapy in juvenile idiopathic arthritis
    Heinrike Schmeling
    Gerd Horneff
    Rheumatology International, 2007, 27 : 383 - 386
  • [4] DEVELOPMENT OF TUMOUR NECROSIS FACTOR (TNF) POLYMORPHISM GENOTYPING AND ASSOCIATION STUDY WITH JUVENILE IDIOPATHIC ARTHRITIS (JIA)
    Zeggini, E.
    Donn, R. P.
    Ollier, W. E. R.
    Richardson, A.
    Kwiatkowski, D.
    Thomson, W.
    RHEUMATOLOGY, 2002, 41 : 3 - 4
  • [5] Tumor necrosis factor alpha promoter polymorphisms in patients with juvenile idiopathic arthritis
    Schmeling, H
    Wagner, U
    Peterson, A
    Horneff, G
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (01) : 103 - 108
  • [6] PARADOXICALLY ELEVATED LEVELS OF TUMOUR NECROSIS FACTOR IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS ON ETANERCEPT
    Fisher, Corinne
    Suffield, Linda
    Radziszewska, Ania
    Hanns, Laura
    Sen, Debajit
    Ioannou, Yiannis
    RHEUMATOLOGY, 2014, 53 : 170 - 170
  • [7] Tumour necrosis factor receptor II polymorphism and juvenile idiopathic arthritis
    Zeggini, E
    Thomson, W
    Alansari, A
    Ollier, W
    Donn, R
    RHEUMATOLOGY, 2002, 41 (04) : 462 - 465
  • [8] Tumour necrosis factor (TNF)-blocking agents in juvenile psoriatic arthritis: are they effective?
    Otten, Marieke H.
    Prince, Femke H. M.
    ten Cate, Rebecca
    van Rossum, Marion A. J.
    Twilt, Marinka
    Hoppenreijs, Esther P. A. H.
    Koopman-Keemink, Yvonne
    Oranje, Arnold P.
    de Waard-van der Spek, Flora B.
    Gorter, Simone L.
    Armbrust, Wineke
    Dolman, Koert M.
    Wulffraat, Nico M.
    van Suijlekom-Smit, Lisette W. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (02) : 337 - 340
  • [9] TREATMENT OF ADULT JUVENILE IDIOPATHIC ARTHRITIS PATIENTS WITH TNF BLOCKERS AND EFFECT OF SWITCHING TO A SECOND ANTI-TNF AGENT
    Jarosova, K.
    Chroust, K.
    Buresova, L.
    Vencovsky, J.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : S14 - S14
  • [10] Anti-tumour necrosis factor (anti-TNF) in the treatment of juvenile idiopathic arthritis-associated uveitis
    C Rivarola
    C Hovhannessian
    A Duquesne
    R Cimaz
    Pediatric Rheumatology, 6 (Suppl 1)
12345